DCPH - Deciphera Pharmaceuticals LLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Deciphera Pharmaceuticals LLC's activity chart (see below) currently has 139 price targets and 114 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.7% with an average time for these price targets to be met of 182.17 days.

Most recent stock forecast was given by from STIFEL on 10-May-2024. First documented stock forecast 23-Oct-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2023

$23

$-2.59 (-10.12%)

$23

2 years 5 months 12 days ago
(10-May-2024)

5/8 (62.5%)

$-2.36 (-9.31%)

108

Sell Since 01-Mar-2022

$26

$0.41 (1.60%)

2 years 5 months 22 days ago
(30-Apr-2024)

2/7 (28.57%)

$0.73 (2.89%)

324

Buy Since 30-Apr-2024

$22

2 years 5 months 22 days ago
(30-Apr-2024)

2/3 (66.67%)

$2.24 (11.34%)

67

Buy Since 29-Apr-2024

$25.6

$0.01 (0.04%)

2 years 5 months 23 days ago
(29-Apr-2024)

0/1 (0%)

$0.32 (1.27%)

Buy Since 29-Apr-2024

$23

2 years 5 months 23 days ago
(29-Apr-2024)

1/2 (50%)

$11.07 (92.79%)

182

Show more analysts

Please expand the browser size to see the chart

What is DCPH (Deciphera Pharmaceuticals LLC) average time for price targets to be met?

On average it took 182 days for the stock forecasts to be reached, with an average price target met ratio of 56.7%.

Which analyst most recently updated their price target on DCPH (Deciphera Pharmaceuticals LLC)?

Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals LLC)?

has 0 price targets and 0 ratings on DCPH

Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals LLC)?

Konstantinos Aprilakis with the highest potential upside of $49.41

Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals LLC)?

Robyn Karnauskas with the lowest potential downside of -$15.59
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?